PremieBreathe is a breathing aid to help premature newborns in resource-constrained settings.
PremieBreathe is a low-cost breathing aid for newborn babies that provides humidified air flow to neonates and was developed by a start-up formed by a multi-departmental collaboration at Yale University. The product is designed for settings that lack safe respiratory devices and is intended to address neonatal mortality due to respiratory complications. In 2016 PremieBreathe was under trial. We have no further updated information as of 2021.
Ethiopia, Malawi, Rwanda
Goal 3: Good health and well-being
Neonatal healthcare personnel: doctors and nurses
This product is currently in the prototyping phase and not yet manufactured at scale. Prototypes are being developed at Yale University in Prof. Gonzalez’s lab.
The designers have not yet selected their user provision model.
None – product still in prototype stage
List or none.
Continuous, Recharging only, None, Other
PremieBreathe, is a humidified high flow nasal cannula (HHFNC) device that delivers variable flows of warmed, humidified, and oxygenated air to provide respiratory support for premature and newborn infants. The device incorporates an ultraviolet water sterilization mechanism to kill waterborne bacteria. It also incorporates reusable, biofouling-resistant tubing rather than the disposable circuit used in the commercial technology, embodied by a mobile, compact housing, designed to incorporate a rechargeable battery source, ensures that our device can provide portable oxygen therapy for critically ill newborns in need of undisrupted support, while in transport between hospitals and health centers.
Provided by the manufacturers
Replacement components include flow regulators and humidification bottles.
The maufacturers set out to develop a low-cost respirator that can safely provide warmed, humidified and blended oxygen to neonates in need.
Pilot tests were performed in Ethiopia at Ayder Referral Hospital to establish the performance and functional parameters after about a half-a-dozen prototyping iterations.
Yale Institute for Global Health, Yale University, Ayder Referral Hospital, and PremieBreathe.
The manufacturers have taken steps to test the device in a clinical environment to ensure its safety.
Wang, D., 2016, “PremieBreathe: A Low-Cost Respiratory Aid for the Developing World.”
Matthews, M., et al., 2017, “PREferred Providers,” ASEE Prism, 27(2), pp. 24-31.
2018, “Third WHO global forum on medical devices: international conference center Geneva: Geneva, Switzerland 10–12 May 2017,” No. WHO/EMP/2018.02,World Health Organization.
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.